$16.94
-0.600 (-3.42%)
At Close: Jun 22, 2026
Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling Upside
02:54am, Thursday, 11'th Jun 2026
Stevanato Group is reiterated as a Buy, driven by robust Q1 results and a compelling long-term growth trajectory. The High-Value Solutions segment accelerated, now comprising 47% of sales, fueled by b
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
10:45am, Tuesday, 09'th Jun 2026
The shares of both stocks are down so far this year. Stevanato is benefiting from the need for GLP-1 injectables.
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
06:30am, Monday, 08'th Jun 2026
PIOMBINO DESE, Italy--(BUSINESS WIRE)-- #DiabetesTherapies--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmace
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' Meeting
05:45pm, Wednesday, 03'rd Jun 2026
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) (the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceuti
Implied Volatility Surging for Stevanato Stock Options
12:51pm, Wednesday, 03'rd Jun 2026
Investors need to pay close attention to STVN stock based on the movements in the options market lately.
Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:00pm, Tuesday, 12'th May 2026
Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript
05:31pm, Thursday, 07'th May 2026
Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates
08:46am, Thursday, 07'th May 2026
Stevanato Group (STVN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.11 per share a year ago.
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
06:30am, Thursday, 07'th May 2026
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group to Participate in Three Upcoming Investor Conferences
05:45pm, Monday, 04'th May 2026
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
11:01am, Thursday, 30'th Apr 2026
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
03:29pm, Monday, 27'th Apr 2026
The Conestoga SMid Cap Composite returned -10.24% net-of-fees in the first quarter, lagging the Russell 2500 Growth Index's return of -3.52%. RBC's performance was driven by continued strength in aero
Reviewing Stevanato Group (NYSE:STVN) and Heatwurx (NASDAQ:PCSA)
01:28am, Monday, 27'th Apr 2026
Heatwurx (NASDAQ: PCSA - Get Free Report) and Stevanato Group (NYSE: STVN - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
04:05pm, Thursday, 23'rd Apr 2026
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
ArrowMark Colorado Holdings LLC Grows Position in Stevanato Group S.p.A. $STVN
04:26am, Sunday, 15'th Mar 2026
ArrowMark Colorado Holdings LLC increased its holdings in Stevanato Group S.p.A. (NYSE: STVN) by 6.7% in the undefined quarter, according to its most recent filing with the SEC. The institutional inve
Sign In
Buy STVN